Squarepoint Ops LLC Exelixis, Inc. Transaction History

Squarepoint Ops LLC

$59.6 Billion
Q2 2024

A detailed history of Squarepoint Ops LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 89,449 shares of EXEL stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,449

Previous 26,097 242.76%

Holding current value

$2.35 Million

Previous $619,000 224.56%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $1.29 Million - $1.5 Million	63,352 Added 242.76%	89,449 $2.01 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $368,465 - $437,153	-18,268 Reduced 41.18%	26,097 $619,000
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $198,737 - $249,118	-10,324 Reduced 18.88%	44,365 $1.06 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $993,699 - $1.12 Million	54,689 New	54,689 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $333,593 - $387,779	22,299 New	22,299 $357,000
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $1.39 Million - $1.84 Million	-79,619 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $356,795 - $474,959	-20,951 Reduced 20.83%	79,619 $1.81 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $4.1 Million - $5.67 Million	-259,142 Reduced 72.04%	100,570 $1.84 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $1.44 Million - $1.87 Million	88,635 Added 32.7%	359,712 $7.6 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $1.61 Million - $2.29 Million	-89,525 Reduced 24.83%	271,077 $4.94 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $5.33 Million - $6.55 Million	259,595 Added 257.01%	360,602 $8.15 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $772,012 - $1.04 Million	41,980 Added 71.12%	101,007 $2.03 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $6.92 Million - $9.02 Million	-334,997 Reduced 85.02%	59,027 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $3.69 Million - $6.14 Million	223,980 Added 131.72%	394,024 $9.35 Million
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $7.83 Million - $11.8 Million	-541,785 Reduced 76.11%	170,044 $2.93 Million
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $6.15 Million - $7.67 Million	406,051 Added 132.79%	711,829 $12.5 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $3.44 Million - $4.4 Million	194,446 Added 174.65%	305,778 $5.41 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $2.11 Million - $2.76 Million	111,332 New	111,332 $2.38 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $1.52 Million - $1.92 Million	-77,356 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $223,750 - $357,345	-16,392 Reduced 17.49%	77,356 $1.52 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $5.16 Million - $7.29 Million	-325,274 Reduced 77.63%	93,748 $1.66 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $5.41 Million - $6.54 Million	291,297 Added 228.07%	419,022 $9.02 Million
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $3.22 Million - $4.63 Million	-145,277 Reduced 53.21%	127,725 $2.83 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $788,201 - $1.01 Million	32,530 Added 13.53%	273,002 $8.3 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $5.62 Million - $7.03 Million	240,472	240,472 $5.83 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.46B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Exelixis, Inc. Transaction History